Details of the Drug Reposition

General Information of This Drug (ID: DMA1QUC)

• Drug Name: CAD-1833 (DMA1QUC)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Spinocerebellar ataxia	DISYMHUK	8A03.16	Phase 1	[1]
Essential tremor or related tremors	DISDQ3M5	8A04.1	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)